BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 17071024)

  • 1. Intrauterine growth restriction and circulating neurotrophin levels at term.
    Malamitsi-Puchner A; Nikolaou KE; Economou E; Boutsikou M; Boutsikou T; Kyriakakou M; Puchner KP; Hassiakos D
    Early Hum Dev; 2007 Jul; 83(7):465-9. PubMed ID: 17071024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine growth restriction, brain-sparing effect, and neurotrophins.
    Malamitsi-Puchner A; Nikolaou KE; Puchner KP
    Ann N Y Acad Sci; 2006 Dec; 1092():293-6. PubMed ID: 17308153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of cord blood neurotrophins in gestational diabetes: the impact of fetal growth abnormalities.
    Briana DD; Papastavrou M; Boutsikou M; Marmarinos A; Gourgiotis D; Malamitsi-Puchner A
    J Matern Fetal Neonatal Med; 2018 Feb; 31(3):278-283. PubMed ID: 28081639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The varying patterns of neurotrophin changes in the perinatal period.
    Nikolaou KE; Malamitsi-Puchner A; Boutsikou T; Economou E; Boutsikou M; Puchner KP; Baka S; Hassiakos D
    Ann N Y Acad Sci; 2006 Dec; 1092():426-33. PubMed ID: 17308169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perinatal changes of plasma resistin concentrations in pregnancies with normal and restricted fetal growth.
    Briana DD; Boutsikou M; Baka S; Gourgiotis D; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
    Neonatology; 2008; 93(3):153-7. PubMed ID: 17878741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates.
    Boutsikou T; Malamitsi-Puchner A; Economou E; Boutsikou M; Puchner KP; Hassiakos D
    Early Hum Dev; 2006 Apr; 82(4):235-9. PubMed ID: 16337100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perinatal bone turnover in term pregnancies: the influence of intrauterine growth restriction.
    Briana DD; Gourgiotis D; Boutsikou M; Baka S; Hassiakos D; Vraila VM; Creatsas G; Malamitsi-Puchner A
    Bone; 2008 Feb; 42(2):307-13. PubMed ID: 18024242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction.
    Briana DD; Boutsikou M; Baka S; Hassiakos D; Gourgiotis D; Malamitsi-Puchner A
    Neonatology; 2009; 96(2):132-6. PubMed ID: 19365143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cord blood netrin-1 and -4 concentrations in term pregnancies with normal, restricted and increased fetal growth.
    Boutsikou T; Giotaki M; Gourgiotis D; Boutsikou M; Briana DD; Marmarinos A; Baka S; Hassiakos D; Malamitsi-Puchner A
    J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1849-53. PubMed ID: 24716747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble fas antigen and soluble fas ligand in intrauterine growth restriction.
    Briana DD; Baka S; Boutsikou M; Liosi S; Vraila VM; Gourgiotis D; Hassiakos D; Malamitsi-Puchner A
    Neonatology; 2010; 97(1):31-5. PubMed ID: 19590243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cystatin C in pregnancies with normal and restricted fetal growth.
    Malamitsi-Puchner A; Briana DD; Kontara L; Boutsikou M; Baka S; Hassiakos D; Marmarinos A; Gourgiotis D
    Reprod Sci; 2007 Jan; 14(1):37-42. PubMed ID: 17636214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perinatal changes of circulating N-terminal pro B-type natriuretic peptide (NT-proBNP) in normal and intrauterine-growth-restricted pregnancies.
    Iacovidou N; Briana DD; Boutsikou M; Gourgiotis D; Baka S; Vraila VM; Hassiakos D; Malamitsi-Puchner A
    Hypertens Pregnancy; 2007; 26(4):463-71. PubMed ID: 18066964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies.
    Briana DD; Boutsikou M; Baka S; Gourgiotis D; Marmarinos A; Liosi S; Hassiakos D; Malamitsi-Puchner A
    Metabolism; 2011 Apr; 60(4):486-90. PubMed ID: 20488498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal steroid exposure in the late preterm period is associated with reduced cord blood neurotrophin-3.
    Hodyl NA; Crawford TM; McKerracher L; Lawrence A; Pitcher JB; Stark MJ
    Early Hum Dev; 2016 Oct; 101():57-62. PubMed ID: 27411106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the anti-angiogenic factor endostatin in intrauterine growth restriction.
    Malamitsi-Puchner A; Boutsikou T; Economou E; Makrakis E; Iliodromiti Z; Kouskouni E; Hassiakos D
    J Soc Gynecol Investig; 2005 Apr; 12(3):195-7. PubMed ID: 15784505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of intrauterine growth restriction on circulating surfactant protein D concentrations in the perinatal period.
    Briana DD; Gourgiotis D; Baka S; Boutsikou M; Vraila VM; Boutsikou T; Hassiakos D; Malamitsi-Puchner A
    Reprod Sci; 2010 Jul; 17(7):653-8. PubMed ID: 20360592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth.
    Briana DD; Boutsikou M; Gourgiotis D; Boutsikou T; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
    J Matern Fetal Neonatal Med; 2008 Nov; 21(11):826-30. PubMed ID: 19031279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrauterine growth restriction may not suppress bone formation at term, as indicated by circulating concentrations of undercarboxylated osteocalcin and Dickkopf-1.
    Briana DD; Gourgiotis D; Georgiadis A; Boutsikou M; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
    Metabolism; 2012 Mar; 61(3):335-40. PubMed ID: 21944272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonates.
    Malamitsi-Puchner A; Boutsikou T; Economou E; Sarandakou A; Makrakis E; Hassiakos D; Creatsas G
    Mediators Inflamm; 2005 Oct; 2005(5):293-7. PubMed ID: 16258196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor (IGF)-I and insulin in normal and growth-restricted mother/infant pairs.
    Malamitsi-Puchner A; Briana DD; Gourgiotis D; Boutsikou M; Puchner KP; Baka S; Marmarinos A; Hassiakos D
    Mediators Inflamm; 2007; 2007():42646. PubMed ID: 17497031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.